Pediatric Oncology News

As part of routine screening for financial hardship, clinicians should discuss an individual’s employment, access to paid leave and health insurance coverage when constructing a treatment plan relating to cancer care.

More than 20% of patients with cancer participate in some form of clinical study, and that number is considered a “floor” estimate, according to study results published in Journal of Clinical Oncology.

Children conceived via fresh or frozen embryo transfer may have increased risk for acute lymphoblastic leukemia compared with children conceived naturally, according to cohort study results published in JAMA Network Open.

A multi-institutional team of researchers created a statistical model capable of predicting the risk for premature menopause among women who survived childhood cancer.

The FDA approved lutetium Lu 177 dotatate for the treatment of pediatric patients aged 12 years and older with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors, including foregut, midgut and hindgut tumors.

The FDA granted accelerated approval to Ojemda for the treatment of certain children with relapsed or refractory low-grade glioma.

The future of pediatric oncology should place a special emphasis on addressing socioeconomic difficulties that childhood cancer survivors face, according to study data published in JAMA Pediatrics.

An innovative combination of drug sensitivity testing and genomics helped identify therapeutic options for children with relapsed or refractory solid or hematologic malignancies, according to results published in Nature Medicine.

Childhood cancer survivors appeared significantly more likely than the general public to die after a major cardiovascular event, according to study results.

Parents of children with cancer made mental health visits, including those for anxiety and depression, significantly more often than other parents, according to results published in JAMA Network Open.